Aflibercept as Primary Treatment for Myopic Choroidal Neovascularisation: A Retrospective Study

Eye - United Kingdom
doi 10.1038/eye.2015.199
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intravitreal Aflibercept for Choroidal Neovascularisation in Angioid Streaks

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2015English

Subretinal Fibrosis After Photodynamic Therapy in Subfoveal Choroidal Neovascularisation in Highly Myopic Eyes

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2003English

Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Polypoidal Choroidal Vasculopathy

Acta Ophthalmologica
MedicineOphthalmology
2017English

Choroidal Neovascularisation at a Demarcation Line: An Immunopathological Study

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Intravitreal Ranibizumab for Choroidal Neovascularisation Secondary to Angioid Streaks

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Choroidal Neovascularisation in Age-Related Macular Disease.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1993English

Efficacy of Aflibercept for Polypoidal Choroidal Vasculopathy in Caucasians

Acta Ophthalmologica
MedicineOphthalmology
2017English

Association Between Choroidal Morphology and Anti-Vascular Endothelial Growth Factor Treatment Outcome in Myopic Choroidal Neovascularization

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Photodynamic Therapy for Inflammatory Choroidal Neovascularisation Unresponsive to Immunosuppression

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy